MSN Laboratories Launches Affordable JAK Inhibitors to Boost Access for Indian Patients

Oct 09, 2025

New Delhi [India], October 9: MSN Laboratories, a leading global Indian pharmaceutical company, today announced that it is the first to launch the revolutionary...

Intas launches DCGI-approved Tofacitinib Topical (JAKi) in Auto-Immune Condition Atopic Dermatitis (AD) for Indian patients

Jun 29, 2023

Ahmedabad (Gujarat) [India], June 29: Intas Pharmaceuticals Ltd., one of India's leading pharmaceutical companies with operations across the globe has launched TOFATAS - a...